

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 7.88917401 |
| 2 | cytidine metabolic process (GO:0046087) | 7.88917401 |
| 3 | cytidine catabolic process (GO:0006216) | 7.88917401 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.13979862 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.78219650 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.73614004 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 6.51101295 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 6.33279454 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.00070559 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.00070559 |
| 11 | DNA deamination (GO:0045006) | 5.84631567 |
| 12 | T cell migration (GO:0072678) | 5.83423421 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.44336173 |
| 14 | negative regulation of cell killing (GO:0031342) | 5.44336173 |
| 15 | positive thymic T cell selection (GO:0045059) | 5.35103169 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 5.34172336 |
| 17 | positive T cell selection (GO:0043368) | 5.32412249 |
| 18 | thymic T cell selection (GO:0045061) | 5.21434734 |
| 19 | viral transcription (GO:0019083) | 5.02011390 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.99749756 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.93257539 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.87484654 |
| 23 | translational termination (GO:0006415) | 4.81409678 |
| 24 | T cell selection (GO:0045058) | 4.78800198 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.63968191 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.59826285 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.55186565 |
| 28 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.55186565 |
| 29 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.39346457 |
| 30 | positive regulation of tolerance induction (GO:0002645) | 4.36804322 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 4.30770359 |
| 32 | T cell receptor signaling pathway (GO:0050852) | 4.29330073 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.28001911 |
| 34 | response to interferon-beta (GO:0035456) | 4.25149945 |
| 35 | T cell costimulation (GO:0031295) | 4.25072612 |
| 36 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.24907166 |
| 37 | translational elongation (GO:0006414) | 4.24738006 |
| 38 | lymphocyte costimulation (GO:0031294) | 4.23034938 |
| 39 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.20637958 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.17537624 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.13880821 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.13358159 |
| 43 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.12602381 |
| 44 | platelet dense granule organization (GO:0060155) | 4.10749999 |
| 45 | ribosomal small subunit biogenesis (GO:0042274) | 4.10315875 |
| 46 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.06898994 |
| 47 | maturation of SSU-rRNA (GO:0030490) | 4.05043731 |
| 48 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.04714957 |
| 49 | cotranslational protein targeting to membrane (GO:0006613) | 4.04169248 |
| 50 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.03966800 |
| 51 | regulation of tolerance induction (GO:0002643) | 4.03582238 |
| 52 | protein targeting to ER (GO:0045047) | 4.00755333 |
| 53 | leukocyte aggregation (GO:0070486) | 3.91687534 |
| 54 | actin nucleation (GO:0045010) | 3.91147361 |
| 55 | lymphoid progenitor cell differentiation (GO:0002320) | 3.91142277 |
| 56 | negative regulation of viral genome replication (GO:0045071) | 3.89953807 |
| 57 | protein localization to endoplasmic reticulum (GO:0070972) | 3.83446149 |
| 58 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.81371586 |
| 59 | defense response to protozoan (GO:0042832) | 3.77582830 |
| 60 | positive regulation of cell killing (GO:0031343) | 3.74781075 |
| 61 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.74578455 |
| 62 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.73492248 |
| 63 | mast cell activation (GO:0045576) | 3.72878528 |
| 64 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69542998 |
| 65 | viral life cycle (GO:0019058) | 3.68466483 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67642843 |
| 67 | lymphocyte chemotaxis (GO:0048247) | 3.66752531 |
| 68 | positive regulation of interleukin-4 production (GO:0032753) | 3.66132519 |
| 69 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.64804284 |
| 70 | lymphocyte migration (GO:0072676) | 3.63170121 |
| 71 | L-fucose catabolic process (GO:0042355) | 3.62905962 |
| 72 | fucose catabolic process (GO:0019317) | 3.62905962 |
| 73 | L-fucose metabolic process (GO:0042354) | 3.62905962 |
| 74 | cellular response to interferon-beta (GO:0035458) | 3.58278280 |
| 75 | regulation of cell killing (GO:0031341) | 3.58266337 |
| 76 | response to protozoan (GO:0001562) | 3.57981323 |
| 77 | cellular protein complex disassembly (GO:0043624) | 3.56613389 |
| 78 | tolerance induction (GO:0002507) | 3.52894991 |
| 79 | activated T cell proliferation (GO:0050798) | 3.50812499 |
| 80 | T cell homeostasis (GO:0043029) | 3.47280373 |
| 81 | regulation of defense response to virus by virus (GO:0050690) | 3.45118147 |
| 82 | regulation of chronic inflammatory response (GO:0002676) | 3.43470209 |
| 83 | endosome to pigment granule transport (GO:0043485) | 3.43039587 |
| 84 | endosome to melanosome transport (GO:0035646) | 3.43039587 |
| 85 | definitive hemopoiesis (GO:0060216) | 3.42636193 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.38176614 |
| 87 | translational initiation (GO:0006413) | 3.31254808 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30894955 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29934793 |
| 90 | positive regulation of interleukin-2 production (GO:0032743) | 3.29842281 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.28817790 |
| 92 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.28050174 |
| 93 | cytolysis (GO:0019835) | 3.28041335 |
| 94 | positive regulation of humoral immune response (GO:0002922) | 3.26798440 |
| 95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23769122 |
| 96 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.21713121 |
| 97 | regulation of interleukin-4 production (GO:0032673) | 3.20632941 |
| 98 | mature B cell differentiation involved in immune response (GO:0002313) | 3.20452505 |
| 99 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19904288 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18324988 |
| 101 | protein complex disassembly (GO:0043241) | 3.18300583 |
| 102 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.16090162 |
| 103 | dendritic cell chemotaxis (GO:0002407) | 3.15987979 |
| 104 | positive regulation of lymphocyte migration (GO:2000403) | 3.15722040 |
| 105 | interferon-gamma production (GO:0032609) | 3.15496161 |
| 106 | positive regulation of T cell chemotaxis (GO:0010820) | 3.14575570 |
| 107 | regulation of T cell chemotaxis (GO:0010819) | 3.14575570 |
| 108 | respiratory burst (GO:0045730) | 3.13815681 |
| 109 | lymph node development (GO:0048535) | 3.13189609 |
| 110 | regulation of activation of Janus kinase activity (GO:0010533) | 3.12389996 |
| 111 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12244385 |
| 112 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.11730455 |
| 113 | megakaryocyte development (GO:0035855) | 3.10199605 |
| 114 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.09944413 |
| 115 | chemokine-mediated signaling pathway (GO:0070098) | 3.08846166 |
| 116 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07732272 |
| 117 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.07314503 |
| 118 | pseudouridine synthesis (GO:0001522) | 3.07306271 |
| 119 | mast cell activation involved in immune response (GO:0002279) | 3.07265419 |
| 120 | mast cell degranulation (GO:0043303) | 3.07265419 |
| 121 | DNA strand elongation (GO:0022616) | 3.06444588 |
| 122 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.05128680 |
| 123 | cellular defense response (GO:0006968) | 3.04126738 |
| 124 | secretory granule organization (GO:0033363) | 3.03245161 |
| 125 | regulation of alpha-beta T cell activation (GO:0046634) | 3.00105001 |
| 126 | positive regulation of T cell mediated immunity (GO:0002711) | 2.99522927 |
| 127 | * regulation of B cell differentiation (GO:0045577) | 2.98588031 |
| 128 | macromolecular complex disassembly (GO:0032984) | 2.98130825 |
| 129 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.96363854 |
| 130 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.94708807 |
| 131 | regulation of viral genome replication (GO:0045069) | 2.93173192 |
| 132 | response to interferon-alpha (GO:0035455) | 2.88956828 |
| 133 | regulation of regulatory T cell differentiation (GO:0045589) | 2.87646250 |
| 134 | mRNA catabolic process (GO:0006402) | 2.83376733 |
| 135 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82210756 |
| 136 | cellular response to type I interferon (GO:0071357) | 2.81470729 |
| 137 | type I interferon signaling pathway (GO:0060337) | 2.81470729 |
| 138 | ribosomal large subunit biogenesis (GO:0042273) | 2.80645003 |
| 139 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.80339298 |
| 140 | telomere maintenance via recombination (GO:0000722) | 2.79387859 |
| 141 | * positive regulation of B cell differentiation (GO:0045579) | 2.79290338 |
| 142 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.79197595 |
| 143 | regulation of natural killer cell activation (GO:0032814) | 2.78849434 |
| 144 | response to type I interferon (GO:0034340) | 2.78839948 |
| 145 | leukocyte homeostasis (GO:0001776) | 2.78621162 |
| 146 | response to interleukin-15 (GO:0070672) | 2.77405857 |
| 147 | myeloid dendritic cell activation (GO:0001773) | 2.73551822 |
| 148 | negative T cell selection (GO:0043383) | 2.72399300 |
| 149 | regulation of necroptotic process (GO:0060544) | 2.71208005 |
| 150 | respiratory chain complex IV assembly (GO:0008535) | 2.70509943 |
| 151 | positive regulation of defense response to virus by host (GO:0002230) | 2.69798130 |
| 152 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.68709566 |
| 153 | tRNA methylation (GO:0030488) | 2.68370380 |
| 154 | RNA catabolic process (GO:0006401) | 2.68306987 |
| 155 | positive regulation of natural killer cell activation (GO:0032816) | 2.66844583 |
| 156 | positive regulation of macrophage differentiation (GO:0045651) | 2.65934017 |
| 157 | protein targeting to membrane (GO:0006612) | 2.65230892 |
| 158 | regulation of response to tumor cell (GO:0002834) | 2.64939464 |
| 159 | positive regulation of response to tumor cell (GO:0002836) | 2.64939464 |
| 160 | positive regulation of immune response to tumor cell (GO:0002839) | 2.64939464 |
| 161 | regulation of immune response to tumor cell (GO:0002837) | 2.64939464 |
| 162 | lymphocyte homeostasis (GO:0002260) | 2.64833526 |
| 163 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.63817339 |
| 164 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.62244154 |
| 165 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.61792308 |
| 166 | mature B cell differentiation (GO:0002335) | 2.61042783 |
| 167 | negative thymic T cell selection (GO:0045060) | 2.59090590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.31307746 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.50420167 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.37455389 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32294147 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25342264 |
| 6 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.07365648 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.05915833 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00036674 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.98519163 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84499724 |
| 11 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.77403504 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75647837 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74398656 |
| 14 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67513663 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67164658 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.65338713 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50898128 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45923462 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.30918542 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.28284887 |
| 21 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.20301708 |
| 22 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16355677 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16008983 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14275557 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.13071172 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13023508 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.09735870 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09218541 |
| 29 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08036994 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.07156104 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.06956244 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.05907506 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.05322107 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 2.03231595 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99669041 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97425526 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.94371597 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90552897 |
| 39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87980859 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87580502 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.87570954 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85922205 |
| 43 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.82083631 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81195352 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79793531 |
| 46 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79480508 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77632507 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76699954 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74740347 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.73465666 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72563325 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72528801 |
| 53 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.71300566 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71262516 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70710401 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.69977913 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64206296 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59565852 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57612332 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56514273 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56379324 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54699820 |
| 63 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48323030 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44965069 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44605735 |
| 66 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43914944 |
| 67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.43841768 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41659137 |
| 69 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39836148 |
| 70 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37101258 |
| 71 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36549582 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35805516 |
| 73 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35772912 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34945016 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34802148 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33881275 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32875370 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.31115958 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30330308 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29638122 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25774555 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25697122 |
| 83 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24242791 |
| 84 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18316879 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18194422 |
| 86 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16758404 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16624404 |
| 88 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16500397 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15889796 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13469413 |
| 91 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12769525 |
| 92 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12299906 |
| 93 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11263073 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10359319 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.07156783 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06465785 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06360268 |
| 98 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06194002 |
| 99 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.06147057 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04827931 |
| 101 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04512309 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03209804 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03011063 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01699007 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.00518483 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99441880 |
| 107 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98790809 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98753605 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96557129 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96209122 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96085683 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95959215 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95137423 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94888473 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94755725 |
| 116 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93625673 |
| 117 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91787844 |
| 118 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91500856 |
| 119 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91134203 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90994313 |
| 121 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.90734086 |
| 122 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.88719758 |
| 123 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85096370 |
| 124 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83481184 |
| 125 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82353650 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80544473 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80416699 |
| 128 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80273352 |
| 129 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79476806 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77374656 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76790458 |
| 132 | SA1_27219007_Chip-Seq_Bcells_Human | 0.76611533 |
| 133 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75717918 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75699884 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.72846248 |
| 136 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.72818938 |
| 137 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.72490030 |
| 138 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72252691 |
| 139 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.71722686 |
| 140 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.70926758 |
| 141 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.70043631 |
| 142 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.69842846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.29509406 |
| 2 | MP0005671_abnormal_response_to | 3.88075307 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.73725165 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 3.66759886 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.63738790 |
| 6 | MP0000685_abnormal_immune_system | 3.54323946 |
| 7 | MP0009785_altered_susceptibility_to | 3.24621747 |
| 8 | MP0005174_abnormal_tail_pigmentation | 2.81042182 |
| 9 | MP0002398_abnormal_bone_marrow | 2.57223704 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.56293730 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.53386542 |
| 12 | MP0005025_abnormal_response_to | 2.50472558 |
| 13 | MP0001800_abnormal_humoral_immune | 2.49734401 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.44415879 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.44261844 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.40715821 |
| 17 | MP0001819_abnormal_immune_cell | 2.37973519 |
| 18 | MP0002723_abnormal_immune_serum | 2.36745264 |
| 19 | MP0001545_abnormal_hematopoietic_system | 2.29416061 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.29416061 |
| 21 | MP0003436_decreased_susceptibility_to | 2.25345164 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.25022530 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.23871087 |
| 24 | * MP0000716_abnormal_immune_system | 2.16552763 |
| 25 | MP0003724_increased_susceptibility_to | 2.15654163 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.14614002 |
| 27 | MP0002722_abnormal_immune_system | 2.13557379 |
| 28 | MP0003866_abnormal_defecation | 2.08857062 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.08386028 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.07197116 |
| 31 | MP0002006_tumorigenesis | 2.04633739 |
| 32 | MP0001873_stomach_inflammation | 2.02401088 |
| 33 | MP0001790_abnormal_immune_system | 2.00376722 |
| 34 | MP0005387_immune_system_phenotype | 2.00376722 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.96027789 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.95081432 |
| 37 | * MP0002429_abnormal_blood_cell | 1.94670532 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.94028599 |
| 39 | MP0000490_abnormal_crypts_of | 1.92940189 |
| 40 | MP0002419_abnormal_innate_immunity | 1.88960708 |
| 41 | MP0003045_fibrosis | 1.87744299 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.87300691 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.85129720 |
| 44 | MP0002405_respiratory_system_inflammati | 1.80626685 |
| 45 | MP0008007_abnormal_cellular_replicative | 1.75659060 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.73587803 |
| 47 | MP0003693_abnormal_embryo_hatching | 1.65197809 |
| 48 | MP0001853_heart_inflammation | 1.63551295 |
| 49 | MP0003448_altered_tumor_morphology | 1.47719376 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.45234448 |
| 51 | MP0010094_abnormal_chromosome_stability | 1.43528242 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.38975132 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.38396071 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.35822310 |
| 55 | MP0008058_abnormal_DNA_repair | 1.33500646 |
| 56 | MP0009379_abnormal_foot_pigmentation | 1.32231382 |
| 57 | MP0008057_abnormal_DNA_replication | 1.29797056 |
| 58 | MP0002933_joint_inflammation | 1.27375721 |
| 59 | MP0008469_abnormal_protein_level | 1.26906345 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.26654400 |
| 61 | MP0003077_abnormal_cell_cycle | 1.24702036 |
| 62 | MP0002132_abnormal_respiratory_system | 1.18098561 |
| 63 | MP0004147_increased_porphyrin_level | 1.15241582 |
| 64 | MP0004947_skin_inflammation | 1.13836049 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.12319584 |
| 66 | MP0000858_altered_metastatic_potential | 1.11871257 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.04533032 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.01742510 |
| 69 | MP0005166_decreased_susceptibility_to | 1.01186998 |
| 70 | MP0006082_CNS_inflammation | 1.00743432 |
| 71 | MP0000371_diluted_coat_color | 0.96159515 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.93858410 |
| 73 | MP0003300_gastrointestinal_ulcer | 0.93692128 |
| 74 | MP0000313_abnormal_cell_death | 0.90317680 |
| 75 | MP0005409_darkened_coat_color | 0.87963828 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.87401100 |
| 77 | MP0002693_abnormal_pancreas_physiology | 0.85732869 |
| 78 | MP0006054_spinal_hemorrhage | 0.85233819 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.83015003 |
| 80 | MP0003111_abnormal_nucleus_morphology | 0.81872400 |
| 81 | MP0002075_abnormal_coat/hair_pigmentati | 0.81632063 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.81508554 |
| 83 | MP0006292_abnormal_olfactory_placode | 0.80290160 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.78647250 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.75588823 |
| 86 | MP0002009_preneoplasia | 0.74653807 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.74273057 |
| 88 | MP0000604_amyloidosis | 0.73776774 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.73265474 |
| 90 | MP0004381_abnormal_hair_follicle | 0.72626704 |
| 91 | MP0001188_hyperpigmentation | 0.72515929 |
| 92 | MP0003075_altered_response_to | 0.71369880 |
| 93 | MP0000477_abnormal_intestine_morphology | 0.71185029 |
| 94 | MP0002163_abnormal_gland_morphology | 0.70047648 |
| 95 | MP0009763_increased_sensitivity_to | 0.69694324 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.69295722 |
| 97 | MP0001663_abnormal_digestive_system | 0.69175557 |
| 98 | MP0001851_eye_inflammation | 0.66919019 |
| 99 | MP0009278_abnormal_bone_marrow | 0.63682872 |
| 100 | MP0001919_abnormal_reproductive_system | 0.63375766 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.61674905 |
| 102 | MP0005310_abnormal_salivary_gland | 0.60760505 |
| 103 | MP0003786_premature_aging | 0.60197095 |
| 104 | MP0005423_abnormal_somatic_nervous | 0.60102917 |
| 105 | MP0009764_decreased_sensitivity_to | 0.57105724 |
| 106 | MP0008873_increased_physiological_sensi | 0.56021458 |
| 107 | MP0001186_pigmentation_phenotype | 0.54279725 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.53992058 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53382462 |
| 110 | MP0003878_abnormal_ear_physiology | 0.53037683 |
| 111 | MP0005377_hearing/vestibular/ear_phenot | 0.53037683 |
| 112 | MP0004510_myositis | 0.52480763 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.51273106 |
| 114 | MP0000358_abnormal_cell_content/ | 0.50395203 |
| 115 | MP0000249_abnormal_blood_vessel | 0.49819117 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.48329411 |
| 117 | MP0000350_abnormal_cell_proliferation | 0.48051976 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.47213623 |
| 119 | MP0000598_abnormal_liver_morphology | 0.47080573 |
| 120 | MP0004883_abnormal_blood_vessel | 0.46802506 |
| 121 | MP0000343_altered_response_to | 0.46572199 |
| 122 | MP0003303_peritoneal_inflammation | 0.45157238 |
| 123 | MP0003646_muscle_fatigue | 0.44679563 |
| 124 | MP0003186_abnormal_redox_activity | 0.44584042 |
| 125 | MP0003795_abnormal_bone_structure | 0.44381326 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.44072871 |
| 127 | MP0001542_abnormal_bone_strength | 0.43630847 |
| 128 | MP0005390_skeleton_phenotype | 0.43220692 |
| 129 | MP0008872_abnormal_physiological_respon | 0.42342050 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.42146689 |
| 131 | MP0003828_pulmonary_edema | 0.42092672 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.40902847 |
| 133 | MP0002102_abnormal_ear_morphology | 0.40693418 |
| 134 | MP0008874_decreased_physiological_sensi | 0.40456923 |
| 135 | MP0005381_digestive/alimentary_phenotyp | 0.40071079 |
| 136 | MP0002168_other_aberrant_phenotype | 0.39284747 |
| 137 | MP0003252_abnormal_bile_duct | 0.38905118 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.38843527 |
| 139 | MP0002083_premature_death | 0.38614801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.18835795 |
| 2 | Thrombocytosis (HP:0001894) | 5.76715694 |
| 3 | Chronic otitis media (HP:0000389) | 5.12702711 |
| 4 | IgM deficiency (HP:0002850) | 4.88175825 |
| 5 | Myositis (HP:0100614) | 4.84006086 |
| 6 | Abnormality of B cell number (HP:0010975) | 4.38182798 |
| 7 | B lymphocytopenia (HP:0010976) | 4.38182798 |
| 8 | Increased IgM level (HP:0003496) | 4.24306418 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.14898841 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 4.13903596 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.11339322 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.04418329 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.63442831 |
| 14 | Obstructive lung disease (HP:0006536) | 3.63442831 |
| 15 | IgG deficiency (HP:0004315) | 3.52257807 |
| 16 | Abnormality of T cells (HP:0002843) | 3.46030133 |
| 17 | Reticulocytopenia (HP:0001896) | 3.35066619 |
| 18 | Nasal polyposis (HP:0100582) | 3.34515319 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.34308493 |
| 20 | Abnormality of the nasal mucosa (HP:0000433) | 3.32214805 |
| 21 | Eosinophilia (HP:0001880) | 3.26282769 |
| 22 | Petechiae (HP:0000967) | 3.23544267 |
| 23 | Type 2 muscle fiber atrophy (HP:0003554) | 3.19404968 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.19300182 |
| 25 | Optic neuritis (HP:0100653) | 3.19300182 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.17822597 |
| 27 | Broad face (HP:0000283) | 3.15112101 |
| 28 | Muscle fiber atrophy (HP:0100295) | 3.13973216 |
| 29 | Severe combined immunodeficiency (HP:0004430) | 3.13720218 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.11891203 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.08768289 |
| 32 | Hypoproteinemia (HP:0003075) | 3.08061234 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.07539927 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.03962941 |
| 35 | T lymphocytopenia (HP:0005403) | 3.03757652 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.02816906 |
| 37 | Orchitis (HP:0100796) | 3.01201471 |
| 38 | Recurrent viral infections (HP:0004429) | 3.00838917 |
| 39 | Hypoplasia of the thymus (HP:0000778) | 3.00559900 |
| 40 | Type I transferrin isoform profile (HP:0003642) | 3.00356538 |
| 41 | * Abnormality of macrophages (HP:0004311) | 2.92046908 |
| 42 | Epistaxis (HP:0000421) | 2.90391121 |
| 43 | Joint swelling (HP:0001386) | 2.86428695 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.83997262 |
| 45 | Poikiloderma (HP:0001029) | 2.83345363 |
| 46 | Increased IgE level (HP:0003212) | 2.82877971 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82559761 |
| 48 | Colon cancer (HP:0003003) | 2.82294869 |
| 49 | Acute lymphatic leukemia (HP:0006721) | 2.78436188 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.76929815 |
| 51 | Albinism (HP:0001022) | 2.75703430 |
| 52 | * Aplastic anemia (HP:0001915) | 2.75479366 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.74529010 |
| 54 | Abnormality of the columella (HP:0009929) | 2.72436863 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.69831200 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.67737709 |
| 57 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.66766142 |
| 58 | Lymphopenia (HP:0001888) | 2.66516792 |
| 59 | Severe visual impairment (HP:0001141) | 2.65967500 |
| 60 | Amaurosis fugax (HP:0100576) | 2.64881593 |
| 61 | IgA deficiency (HP:0002720) | 2.64510453 |
| 62 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.63407710 |
| 63 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.63407710 |
| 64 | Abnormal protein glycosylation (HP:0012346) | 2.63407710 |
| 65 | Abnormal glycosylation (HP:0012345) | 2.63407710 |
| 66 | Thyroiditis (HP:0100646) | 2.62547135 |
| 67 | Combined immunodeficiency (HP:0005387) | 2.62183364 |
| 68 | Hemoptysis (HP:0002105) | 2.61052121 |
| 69 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58444160 |
| 70 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58444160 |
| 71 | Recurrent otitis media (HP:0000403) | 2.55850115 |
| 72 | Pallor (HP:0000980) | 2.55195522 |
| 73 | Macrocytic anemia (HP:0001972) | 2.50544679 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.50178437 |
| 75 | Acute myeloid leukemia (HP:0004808) | 2.50073165 |
| 76 | Reduced antithrombin III activity (HP:0001976) | 2.49300881 |
| 77 | Meningitis (HP:0001287) | 2.48689978 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.48665061 |
| 79 | * Lymphoma (HP:0002665) | 2.46416919 |
| 80 | Pulmonary embolism (HP:0002204) | 2.44266699 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.44084351 |
| 82 | Microcytic anemia (HP:0001935) | 2.43358783 |
| 83 | Acute hepatic failure (HP:0006554) | 2.41923190 |
| 84 | Gangrene (HP:0100758) | 2.38962441 |
| 85 | Urticaria (HP:0001025) | 2.38303272 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.37528832 |
| 87 | Stomatitis (HP:0010280) | 2.36132095 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.36054472 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35534094 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35534094 |
| 91 | Gingival bleeding (HP:0000225) | 2.35465655 |
| 92 | Recurrent skin infections (HP:0001581) | 2.35387761 |
| 93 | Chronic sinusitis (HP:0011109) | 2.35173923 |
| 94 | Skin rash (HP:0000988) | 2.31681526 |
| 95 | Bronchitis (HP:0012387) | 2.31447538 |
| 96 | Hepatocellular necrosis (HP:0001404) | 2.29343852 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.29034375 |
| 98 | Granulocytopenia (HP:0001913) | 2.28929502 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28009388 |
| 100 | Colitis (HP:0002583) | 2.26501266 |
| 101 | Purpura (HP:0000979) | 2.24926425 |
| 102 | Chronic diarrhea (HP:0002028) | 2.24692900 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.21180183 |
| 104 | 3-Methylglutaconic aciduria (HP:0003535) | 2.20024067 |
| 105 | Restrictive lung disease (HP:0002091) | 2.19816451 |
| 106 | Sepsis (HP:0100806) | 2.18809312 |
| 107 | Erythema (HP:0010783) | 2.18024233 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.15930870 |
| 109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.15548065 |
| 110 | Subaortic stenosis (HP:0001682) | 2.15548065 |
| 111 | Verrucae (HP:0200043) | 2.15350930 |
| 112 | Papilloma (HP:0012740) | 2.15350930 |
| 113 | Abnormality of eosinophils (HP:0001879) | 2.14638166 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.12734029 |
| 115 | Hypochromic anemia (HP:0001931) | 2.11481615 |
| 116 | Myelodysplasia (HP:0002863) | 2.09811400 |
| 117 | Encephalitis (HP:0002383) | 2.05557163 |
| 118 | Vasculitis (HP:0002633) | 2.04674854 |
| 119 | Pulmonary fibrosis (HP:0002206) | 2.01349605 |
| 120 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98962216 |
| 121 | Abnormal platelet function (HP:0011869) | 1.98690834 |
| 122 | Impaired platelet aggregation (HP:0003540) | 1.98690834 |
| 123 | Abnormality of the prostate (HP:0008775) | 1.98612968 |
| 124 | Entropion (HP:0000621) | 1.97816456 |
| 125 | * Pancytopenia (HP:0001876) | 1.97432600 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 1.96240553 |
| 127 | Chest pain (HP:0100749) | 1.96188590 |
| 128 | Hepatic necrosis (HP:0002605) | 1.96131059 |
| 129 | Pustule (HP:0200039) | 1.94756633 |
| 130 | Ureteral stenosis (HP:0000071) | 1.94738010 |
| 131 | Mediastinal lymphadenopathy (HP:0100721) | 1.94665199 |
| 132 | Hemiplegia (HP:0002301) | 1.94505246 |
| 133 | Leukocytosis (HP:0001974) | 1.92671998 |
| 134 | Arthralgia (HP:0002829) | 1.91538180 |
| 135 | Neutropenia (HP:0001875) | 1.89117424 |
| 136 | Glomerulopathy (HP:0100820) | 1.88268684 |
| 137 | Eczematoid dermatitis (HP:0000976) | 1.88202749 |
| 138 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84173698 |
| 139 | Cellulitis (HP:0100658) | 1.83804025 |
| 140 | Oral leukoplakia (HP:0002745) | 1.83259158 |
| 141 | Polyneuropathy (HP:0001271) | 1.81646853 |
| 142 | Emphysema (HP:0002097) | 1.81415103 |
| 143 | Ureteral obstruction (HP:0006000) | 1.81201555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.39413232 |
| 2 | FLT3 | 3.60337233 |
| 3 | KIT | 3.59424152 |
| 4 | NME2 | 3.41584374 |
| 5 | TXK | 3.00707373 |
| 6 | STK16 | 2.79690362 |
| 7 | CSK | 2.63757133 |
| 8 | EEF2K | 2.56862915 |
| 9 | TEC | 2.50744227 |
| 10 | ZAP70 | 2.35477648 |
| 11 | CSF1R | 2.28344727 |
| 12 | BTK | 2.08299089 |
| 13 | JAK3 | 2.08235012 |
| 14 | PIM2 | 2.01423559 |
| 15 | WEE1 | 1.95800980 |
| 16 | CDK19 | 1.90174822 |
| 17 | TNIK | 1.87751079 |
| 18 | KDR | 1.86341296 |
| 19 | TBK1 | 1.86267171 |
| 20 | MAP2K3 | 1.81168925 |
| 21 | TGFBR1 | 1.76855866 |
| 22 | MAPKAPK5 | 1.63073626 |
| 23 | IKBKE | 1.60477476 |
| 24 | PRKCQ | 1.60045145 |
| 25 | SCYL2 | 1.55336008 |
| 26 | SYK | 1.54384556 |
| 27 | ADRBK2 | 1.51809806 |
| 28 | FES | 1.45273003 |
| 29 | TESK1 | 1.43023010 |
| 30 | MUSK | 1.39447068 |
| 31 | RPS6KB2 | 1.37080228 |
| 32 | BCKDK | 1.35058390 |
| 33 | TYK2 | 1.34716763 |
| 34 | TGFBR2 | 1.30945962 |
| 35 | MAP3K12 | 1.30916914 |
| 36 | MAPKAPK3 | 1.30555853 |
| 37 | NLK | 1.25734955 |
| 38 | LCK | 1.25476652 |
| 39 | BLK | 1.23473950 |
| 40 | IRAK4 | 1.22902283 |
| 41 | ITK | 1.21821082 |
| 42 | ACVR1B | 1.12441850 |
| 43 | TLK1 | 1.09627634 |
| 44 | MAP3K7 | 1.06284906 |
| 45 | BUB1 | 1.06086137 |
| 46 | LYN | 1.01150672 |
| 47 | DYRK3 | 0.96482338 |
| 48 | RPS6KA4 | 0.94075056 |
| 49 | IKBKB | 0.93858834 |
| 50 | MST4 | 0.92808068 |
| 51 | MAP3K11 | 0.92667028 |
| 52 | PRPF4B | 0.89978162 |
| 53 | LRRK2 | 0.89889712 |
| 54 | VRK1 | 0.88337215 |
| 55 | MAP2K7 | 0.87883516 |
| 56 | MATK | 0.86715373 |
| 57 | RAF1 | 0.86563827 |
| 58 | FYN | 0.85960483 |
| 59 | CCNB1 | 0.85866024 |
| 60 | CAMKK2 | 0.85387010 |
| 61 | GRK7 | 0.81895073 |
| 62 | HCK | 0.79273069 |
| 63 | NEK2 | 0.79101510 |
| 64 | BRSK2 | 0.78941902 |
| 65 | CAMKK1 | 0.78640334 |
| 66 | CAMK1 | 0.78440236 |
| 67 | CDC7 | 0.78049054 |
| 68 | MAP3K6 | 0.75570189 |
| 69 | TYRO3 | 0.75474637 |
| 70 | EIF2AK1 | 0.72296240 |
| 71 | MAP2K6 | 0.71350840 |
| 72 | MAP3K10 | 0.66745133 |
| 73 | PRKG2 | 0.66358905 |
| 74 | FGR | 0.66001031 |
| 75 | PIM1 | 0.65854016 |
| 76 | STK10 | 0.65306507 |
| 77 | MARK3 | 0.64589660 |
| 78 | PASK | 0.64318148 |
| 79 | GRK6 | 0.63113610 |
| 80 | PDK1 | 0.62890053 |
| 81 | CDK7 | 0.62876594 |
| 82 | DAPK1 | 0.60180033 |
| 83 | ATR | 0.58513845 |
| 84 | MARK2 | 0.55923643 |
| 85 | FGFR4 | 0.55052569 |
| 86 | TAOK3 | 0.54608019 |
| 87 | PKN2 | 0.54332782 |
| 88 | MAPK11 | 0.54058201 |
| 89 | MAP3K5 | 0.53264381 |
| 90 | PRKCH | 0.53057196 |
| 91 | JAK1 | 0.52346941 |
| 92 | TESK2 | 0.52106586 |
| 93 | TAOK2 | 0.51517148 |
| 94 | SIK3 | 0.51215534 |
| 95 | MAP3K14 | 0.51047830 |
| 96 | PIK3CA | 0.50994709 |
| 97 | ILK | 0.50133616 |
| 98 | EIF2AK3 | 0.48274653 |
| 99 | TSSK6 | 0.47350978 |
| 100 | MAPK4 | 0.46462329 |
| 101 | VRK2 | 0.46389394 |
| 102 | TAOK1 | 0.45535437 |
| 103 | BMPR2 | 0.45384777 |
| 104 | CDK4 | 0.45360377 |
| 105 | CAMK4 | 0.44716444 |
| 106 | CDK8 | 0.43910504 |
| 107 | TNK2 | 0.43334987 |
| 108 | INSR | 0.43233893 |
| 109 | RIPK4 | 0.43200830 |
| 110 | HIPK2 | 0.42651481 |
| 111 | ERN1 | 0.40910730 |
| 112 | MKNK1 | 0.38787871 |
| 113 | MAP3K13 | 0.38577629 |
| 114 | LIMK1 | 0.38176310 |
| 115 | MYLK | 0.36863366 |
| 116 | MAP3K3 | 0.36743545 |
| 117 | PIK3CG | 0.35507658 |
| 118 | ZAK | 0.35139672 |
| 119 | MAP3K1 | 0.34884455 |
| 120 | RPS6KA5 | 0.34523607 |
| 121 | SIK2 | 0.34496852 |
| 122 | SRPK1 | 0.34316775 |
| 123 | IGF1R | 0.34091865 |
| 124 | JAK2 | 0.33477244 |
| 125 | MAPK12 | 0.33415504 |
| 126 | CSNK1G3 | 0.33160872 |
| 127 | MAPKAPK2 | 0.32450983 |
| 128 | TIE1 | 0.31089868 |
| 129 | BRSK1 | 0.31014748 |
| 130 | CLK1 | 0.30559688 |
| 131 | EPHB1 | 0.30054799 |
| 132 | PDGFRB | 0.29839017 |
| 133 | GRK1 | 0.29710214 |
| 134 | NUAK1 | 0.27689522 |
| 135 | PAK1 | 0.25208874 |
| 136 | ABL1 | 0.20688139 |
| 137 | MAPK3 | 0.19938138 |
| 138 | CHUK | 0.19138978 |
| 139 | ROCK1 | 0.18908996 |
| 140 | PRKCD | 0.18686445 |
| 141 | MAPK7 | 0.16718927 |
| 142 | MELK | 0.16182177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.30452762 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.01524540 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.88808284 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.95824157 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.82958954 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.69621119 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.34344963 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.12985941 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07862524 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.06909537 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.05352170 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03414832 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.97644449 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.97215629 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96907487 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.84503283 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79683756 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.76924323 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76263966 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.75361030 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72643056 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.72480471 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72172410 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.61477530 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60673615 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60559836 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58366139 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57671845 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57422393 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.56723557 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.50806506 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44167961 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43485900 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35853728 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.35159997 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29614425 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27487002 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.16885388 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.11241969 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08647782 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08203186 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07765093 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.05342827 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03108184 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03003239 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.01178027 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96803317 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96411015 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95865949 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93132322 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92027249 |
| 52 | Protein export_Homo sapiens_hsa03060 | 0.91862476 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.91535124 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.89457194 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88043987 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86167358 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85690070 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.84404809 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84171602 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.79290848 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78431728 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.78305860 |
| 63 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77370356 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76542883 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.76311121 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 0.74900137 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74519292 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73723880 |
| 69 | Cell cycle_Homo sapiens_hsa04110 | 0.73654552 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71355312 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70115597 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66349252 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66101942 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65141591 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.65134358 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.63312252 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62571976 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62001066 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61910980 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58997873 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58129053 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57591738 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.57506892 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57027266 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56109679 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55989241 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55523008 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.51850440 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50838030 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50365680 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49877849 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47761304 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47106726 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46097496 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43890208 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.43592691 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42600592 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41433219 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35755308 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35716660 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35594818 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34940224 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32713583 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.31781920 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31308940 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30326739 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30032216 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.29948190 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29606395 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25641088 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24386651 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23859405 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23484374 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23277614 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.22738053 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22526851 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.22357916 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21956113 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21019734 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20958633 |
| 121 | Phototransduction_Homo sapiens_hsa04744 | 0.17831756 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17615474 |
| 123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17455680 |
| 124 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13048280 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07512716 |
| 126 | Olfactory transduction_Homo sapiens_hsa04740 | 0.05729521 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.04449719 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.00384993 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.00259652 |
| 130 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0623850 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0418332 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0237424 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0234309 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0224032 |
| 135 | Lysosome_Homo sapiens_hsa04142 | -0.0117501 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0109669 |

